Normal view MARC view ISBD view

Peritoneal Metastases, a Frontier for Progress. [Review] - 2018

Available online through MWHC library: 2002 - present, Available in print through MWHC library: 1999 - January 2007

Copyright (c) 2018 Elsevier Inc. All rights reserved. The treatments for peritoneal metastases have evolved over 30 years. Now the concepts that guided clinicians are being tested in clinical trials to optimize standardized treatment regimens. The essential features of a successful management plan are cytoreductive surgery combined with cancer chemotherapy in a large volume of intraperitoneal fluid administered into the peritoneal space. The cytotoxicity of the cancer chemotherapy is maximized by moderate hyperthermia. The patients must be carefully selected using well-defined prognostic indicators. The efforts to date are multinational with centers of excellence located throughout the world.


English

ISSN: 1055-3207

Standard No.: 10.1016/j.soc.2018.02.001 [doi] S1055-3207(18)30011-5 [pii]

Subjects--Topical Terms:
*Neoplasms/pa [Pathology]
*Peritoneal Neoplasms/sc [Secondary]
Humans
Prognosis

Subjects--Geographic Terms:
Washington Cancer Institute

Index Terms--Function:
Journal Article
Review